LivaNova PLC (LIVN)
NASDAQ: LIVN · Real-Time Price · USD
45.23
+1.17 (2.66%)
At close: May 12, 2025, 4:00 PM
45.25
+0.02 (0.04%)
After-hours: May 12, 2025, 4:10 PM EDT
LivaNova Market Cap
LivaNova has a market cap or net worth of $2.47 billion as of May 12, 2025. Its market cap has decreased by -18.29% in one year.
Market Cap
2.47B
Enterprise Value
2.41B
1-Year Change
-18.29%
Ranking
Category
Stock Price
$45.23
Market Cap Chart
Since October 19, 2015, LivaNova's market cap has decreased from $3.42B to $2.47B, a decrease of -27.79%. That is a compound annual growth rate of -3.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 2.40B | -4.47% |
| Dec 31, 2024 | 2.51B | -9.78% |
| Dec 29, 2023 | 2.79B | -6.24% |
| Dec 30, 2022 | 2.97B | -36.12% |
| Dec 31, 2021 | 4.65B | 44.63% |
| Dec 31, 2020 | 3.22B | -11.87% |
| Dec 31, 2019 | 3.65B | -18.02% |
| Dec 31, 2018 | 4.45B | 15.57% |
| Dec 29, 2017 | 3.85B | 75.67% |
| Dec 30, 2016 | 2.19B | -24.35% |
| Dec 31, 2015 | 2.90B | -15.10% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.08B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |